Companion Animal Market Trends
Interesting Report from Idexx to download here
Category Industry News
Vetoquinol USA received a regulatory go-ahead for Imoxi Topical Solution for Cats
The U.S. Food and Drug Administration has approved Vetoquinol USA’s Imoxi Topical Solution for Cats, a generic equivalent of Bayer’s Advantage Multi antiparasitic. Imoxi Topical Solution for Cats (imidacloprid and moxidectin) is formulated to prevent heartwormsand treat fleas, ear mites…
Merck to Acquire Sentinel
Merck Animal Health has reached an agreement with Virbac to acquire the U.S. rights to Sentinel Flavor Tabs (milbemycin oxime/lufenuron) and Sentinel Spectrum Chews (milbemycin oxime/lufenuron/praziquantel) for approximately $400 million, according to a company press release.
New from Idexx: COVID-19 pet test
Responding to customer demand, Idexx Laboratories Inc. has released a COVID-19 test for pets. The SARS-CoV-2 (COVID-19) RealPCR Test is available to North American veterinarians and will be shipped worldwide “in the coming weeks,” Idexx stated. The company pointed to…
Temporary Suspension of Pro Plan Wellness Diets
This note is to inform you that as of 4/14/20 we will be temporarily suspending the following Pro Plan Wellness Diets. At this time, I don’t have any insight into when we will be turning these products back on, but…
Zoetis Receives FDA Approval for Simparica Trio
PARSIPPANY, N.J.–(BUSINESS WIRE)–Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets), the first once-monthly, chewable tablet in the U.S. that delivers all-in-one protection from heartworm disease, ticks and…
Elanco and Bayer divestment updates
So far in 2020, Elanco and Bayer have agreed to sell: Vecoxan (diclazuril), an oral drench for the prevention and treatment of coccidiosis in calves and lambs, to Merck. Osurnia (florfenicol, terbinafine, betamethasone acetate), for the treatment of otitis externa…
COVID-19 Product Allocation List
As you’ve seen on our site, we have implemented some allocations to prevent runs on certain high use Infectious disease items while global supply chains are stressed. Here’s the latest list.